Investigator
Jonathan R. Lai
ALBERT EINSTEIN COLLEGE OF MEDICINE · funded by NIAID
- Companies
- 1
- Grants
- 2
- Non-dilutive funding
- $1.6M
- First award
- Sep 24, 2021
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 6, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- Guangdong Association of Clinical Trials100momentum
OncologyPhase III
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Human antibodies as broad alphavirus immunotherapeutics
$844kJun 6, 2025NIAIDALBERT EINSTEIN COLLEGE OF MEDICINENIH RePORTER · 11104757 (opens the source filing in a new tab)
- R01
Structure-based design of broad flavivirus immunogens
$739kSep 24, 2021NIAIDALBERT EINSTEIN COLLEGE OF MEDICINENIH RePORTER · 11144985 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources